Document is current

Any future updates will be listed below

Early administration of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12872-024-04057-w

Published Online: 2024-07-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark